About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,985 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,985 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1321-1340 of 7,985 trials

RecruitingPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCDESTINY-Lung03 will investigate the safety and tolerability of trastuzumab deruxtecan in combination with Immunotherapy Agents with and without chemotherapy in patients with HER2…NCT04686305·Duarte, California and 90 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedStudy of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)In this study, participants with programmed cell death ligand 1 (PD-L1)-positive non-small cell lung cancer (NSCLC) will be randomized to receive single agent pembrolizumab for up…NCT02220894

RecruitingNitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.The goal of this interventional phase III clinical trial is to evaluate objective intracranial response rate (iORR) after a treatment with total cranial radiation therapy plus…NCT06238882·Mexico City, Mexico City

RecruitingA Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)This trial is a registrational Phase II/III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 in combination with osimertinib in…NCT07642024·Shanghai, Shanghai Municipality and 1 other

CompletedEpidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)To estimate the prevalence of EGFR mutation in a representative sample of patients with newly diagnosed stage IIIB/IV NSCLC in Spain (predominantly Caucasian ethnicity).NCT01081496·Santiago de Compostela, A Coruna and 23 others

RecruitingTRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%This prospective, multicenter, real-world observational study aims to evaluate the clinical outcomes of first-line atezolizumab monotherapy in patients with stage IV non-small…NCT07279402·Adana and 24 others

Not yet recruitingGlumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer PatientsTo evaluate the efficacy and safety of glumetinib combined with osimertinib as the first-line treatment for locally advanced or metastatic NSCLC.NCT06908772

UnknownIntravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesThis an an open-label study to define the safety profile and the maximum tolerated dose and confirm the clinical effective dose of palifosfamide-tris given intravenously in…NCT01242072·Indianapolis, Indiana and 3 others

UnknownCisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung CancerAdvanced non-small-cell lung cancer (NSCLC) patients without epidermal growth factor receptor (EGFR) mutations show a poor prognosis.NCT01623102·Chengdu, Sichuan and 1 other

TerminatedTrial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung CancerThe purpose of the study is to determine in patients with Non Small Cell Lung Cancer refractory to previous chemotherapy whether concomitant treatment with cetuximab and…NCT00203931·Chicago, Illinois

CompletedNT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsThe main purposes of Phase 1b of this study are to determine the following in participants with advanced solid tumors: * Safety and tolerability of NT-I7 in combination with…NCT04332653·Tampa, Florida and 7 others

TerminatedAzacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)This is an open-label, Phase 1/2 study in subjects with advanced or metastatic solid tumors.NCT02959437·Duarte, California and 11 others

UnknownS-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLCTo investigate the survival benefit of first-line therapy for patients with EGFR-sensitive mutation-positive advanced non-squamous non-small cell lung cancer treated with S-1plus…NCT03457337·Zhengzhou, Henan

CompletedComputed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung CancerThis study will evaluate the impact of CT-guided adaptive stereotactic radiotherapy (CT-STAR) to central and ultra-central early-stage non-small cell lung cancers on grade 3 or…NCT05785845·St Louis, Missouri

TerminatedImmune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung CancerLung cancer is still the leading cause of cancer related-deaths worldwide, with an overall all-stage 5-year survival of approximately 17%.NCT03030131·Amiens and 30 others

CompletedPhase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)This phase Ib study will investigate dose limiting toxicity (DLT) and maximum tolerated dose (MTD) of afatinib and ruxolitinib combination therapy, based on the preclinical data…NCT02145637

UnknownExamination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study ExperiencesMedical study participation percentages haven't always been fully representative of a given demographic.NCT05778045

UnknownA Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver GenesA single-center, non-interventional prospective observational study in the NSCLC patients with different driver genesNCT03710629·Guangzhou, Guangdong

RecruitingThe Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung CancerThis randomized phase II trial is to explore the clinical efficacy, safety and feasibility of neoadjuvant immunotherapy plus radiotherapy compared with neoadjuvant immunotherapy…NCT05798845·Shanghai, Shanghai Municipality

TerminatedXZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung CancerThe trial is divided into two parts, one is dose escalation phase, the second one is dose expansion phase.NCT04622072·Beijing, Beijing Municipality and 4 others

PreviousPage 67 of 400Next